Skip to main content

Advertisement

SpringerLink
Log in

Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer’s disease

  • Original Article
  • Published:
Acta Neurologica Belgica Aims and scope Submit manuscript

An Erratum to this article was published on 07 March 2014

Abstract

To investigate aberrant genome-wide CpG methylation patterns in cortex brain tissue of APP/PS1 mice and as compared to controls, which allows for identification of novel disease-associated genes. This study investigates the genome-wide DNA methylation profiles of the cortex from APP/PS1 transgenic mice and control mice using the Roche NimbleGen chip platform. Functional analysis was then conducted by Ingenuity Pathways Analysis system. The methylated DNA fragments in the genome of each sample were enriched by MeDIP and the whole-genome interrogations were hybridized to the Roche NimbleGen Human DNA Methylation 3x720 K CpG Island Plus RefSeq Promoter Array that cover 15,980 CpG islands and 20,404 reference gene promoter regions of the entire human genome. Analysis reveals 2346 CpG sites representing 485 unique genes as potentially associated with AD disease status pending confirmation in additional study. At the same time, these hyper-methylated genes display familial aggregation. An impairment of the transforming growth factor-β1 (TGF-β1) signaling pathway has been demonstrated to be specific to the AD brain and, particularly, to the early phase of the disease, supporting a role for epigenetic change of TGF-β1 in AD pathology. In future research, we will focus on TGF-β1, as it appeared to be the most promising candidate for AD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Lue LF, Brachova L, Civin WH, Rogers J (1996) Inflammation, a beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer’s disease neurodegeneration. J Neuropathol Exp Neurol 55:1083–1088

    CAS  PubMed  Google Scholar 

  2. Mastroeni D, Mckee A, Grover A, Rogers J, Coleman PD (2009) Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer’s disease. PLoS One 4:e6617

    Article  PubMed  PubMed Central  Google Scholar 

  3. Räihä I, Kaprio J, Koskenvuo M, Rajala T, Sourander L (1997) Alzheimer’s disease in twins. Biomed Pharmacother 51:101–104

    Article  PubMed  Google Scholar 

  4. Bakulski KM, Dolinoy DC, Sartor MA, Paulson HL, Konen JR, Lieberman AP et al (2012) Genome-wide DNA methylation differences between late-onset Alzheimer’s disease and cognitively normal controls in human frontal cortex. J Alzheimer’s Dis 29:571–588

    CAS  Google Scholar 

  5. Felsenfeld G (2007) A brief history of epigenetics. In: Allis CD, Jenuwein T, Reinberg D (eds) Epigenetics. Cold Spring Harbor Laboratory Press, Maine, pp 15–22

    Google Scholar 

  6. Mastroeni D, Grover A, Elaine Delvaux E, Whiteside C, Coleman PD, Rogers J (2011) Epigenetic mechanisms in Alzheimer’s disease. Neurobiol Aging 32:1161–1180

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D’Souza C, Fouse SD et al (2010) Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 466:253–257

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Jin SG, Wu X, Li AX, Pfeifer GP (2011) Genomic mapping of 5-hydroxymethylcytosine in the human brain. Nucleic Acids Res 39:5015–5024

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Genda Y, Ukitsu M (1999) Reduction with age in methylcytosine in the promoter region -224 approximately -101 of the amyloid precursor protein gene in autopsy human cortex. Brain Res Mol Brain Res 70:288–292

    CAS  PubMed  Google Scholar 

  10. Tohgi H, Utsugisawa K, Nagane Y, Yoshimura M, Ukitsu M, Genda Y (1999) The methylation status of cytosines in a tau gene promoter region alters with age to downregulate transcriptional activity in human cerebral cortex. Neurosci Lett 275:89–92

    Article  CAS  PubMed  Google Scholar 

  11. Barrachina M, Ferrer I (2009) DNA methylation of Alzheimer disease and tauopathy-related genes in postmortem brain. J Neuropathol Exp Neurol 68:880–891

    CAS  PubMed  Google Scholar 

  12. Mill J (2011) Toward an integrated genetic and epigenetic approach to Alzheimer’s disease. Neurobiol Aging 32:1188–1191

    Article  CAS  PubMed  Google Scholar 

  13. Chouliaras L, Rutten BP, Kenis G, Peerbooms O, Visser PJ, Verhey F et al (2010) Epigenetic regulation in the pathophysiology of Alzheimer’s disease. Prog Neurobiol 90:498–510

    Article  CAS  PubMed  Google Scholar 

  14. Verret L, Jankowsky JL, Xu GM, Borchelt DR, Rampon C (2007) Alzheimer’s-type amyloidosis in transgenic mice impairs survival of newborn neurons derived from adult hippocampal neurogenesis. J Neurosci 27:6771–6780

    Article  CAS  PubMed  Google Scholar 

  15. Lalonde R, Kim HD, Fukuchi K (2004) Exploratory activity, anxiety, and motor coordination in bigenic APPswe t PS1/DeltaE9 mice. Neurosci Lett 369:156e61

    Article  Google Scholar 

  16. Dewachter I, Reversé D, Caluwaerts N, Ris L, Kuipéri C, Van den Haute C et al (2002) Neuronal deficiency of presenilin 1 inhibits amyloid plaque formation and corrects hippocampal long-term potentiation but not a cognitive defect of amyloid precursor protein [V717I] transgenic mice. J Neurosci 22:3445e53

    Google Scholar 

  17. Spuch C, Antequera D, Portero A, Orive G, Hernandez RM, Molina JA et al (2010) The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer’s disease. Biomaterials 31:5608–5618

    Article  CAS  PubMed  Google Scholar 

  18. Zhang Y, Liu T, Meyer CA, Eeckhoute J, Johnson DS et al (2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol 9:R137

    Article  PubMed  PubMed Central  Google Scholar 

  19. Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102(43):15545–15550

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Aguilera O, Fernandez AF, Munoz A, Fraga MF (2010) Epigenetics and environment: a complex relationship. J Appl Physiol 109:243–251

    Article  CAS  PubMed  Google Scholar 

  21. Dolinoy DC, Weidman JR, Jirtle RL (2007) Epigenetic gene regulation: linking early developmental environment to adult disease. Reprod Toxicol 23:297–307

    Article  CAS  PubMed  Google Scholar 

  22. Jirtle RL, Skinner MK (2007) Environmental epigenomics and disease susceptibility. Nat Rev Genet 8:253–262

    Article  CAS  PubMed  Google Scholar 

  23. Movassagh M, Choy MK, Goddard M, Bennett MR, Down TA, Foo RS (2010) Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PLoS One 5:e8564

    Article  PubMed  PubMed Central  Google Scholar 

  24. Li M, Balch C, Montgomery JS, Jeong M, Chung JH, Yan P et al (2009) Integrated analysis of DNA methylation and gene expression reveals specific signaling pathways associated with platinum resistance in ovarian cancer. BMC Med Genomics 2:34

    Article  PubMed  PubMed Central  Google Scholar 

  25. Xin Yurong, Chanrion Benjamin, Liu Meng-Min (2010) Genome-wide divergence of DNA methylation marks in cerebral and cerebellar cortices. PLoS One 5(6):e11357

    Article  PubMed  PubMed Central  Google Scholar 

  26. Wyss-Coray T, Masliah E, Mallory M, McConlogue L, Johnson-Wood K, Lin C, Mucke L (1997) Amyloidogenic role of cytokine TGF-beta1 in transgenic mice and in Alzheimer’s disease. Nature 389(6651):603–606

    Article  CAS  PubMed  Google Scholar 

  27. Caraci F, Spampinato S, Sortino MA, Bosco P, Battaglia G, Bruno V, Drago F, Nicoletti F, Copani A (2012) Dysfunction of TGF-β1 signaling in Alzheimer’s disease: perspectives for neuroprotection. Cell Tissue Res 347(1):291–301

    Article  CAS  PubMed  Google Scholar 

  28. Ten Dijke P, Hill CS (2004) New insights into TGF-beta-Smad signalling. Trends Biochem Sci 29:265–273

    Article  PubMed  Google Scholar 

  29. Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006) Transforming growth factor-β regulation of immune responses. Annu Rev Immunol 24:99–146

    Article  CAS  PubMed  Google Scholar 

  30. Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV et al (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J Clin Invest 116:3060–3069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Caraci F, Battaglia G, Bruno V, Bosco P, Carbonaro V, Giuffrida ML et al (2009) TGF-beta1 pathway as a new target for neuroprotection in Alzheimer’s disease. CNS Neurosci Ther 17:237–249

    Article  PubMed  Google Scholar 

  32. Wang H, Liu J, Zong Y, Xu Y, Zhu H, Deng W et al (2010) miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer’s disease targets TGF-β type II receptor. Brain Res 1357:166–174

    CAS  PubMed  Google Scholar 

  33. Lee HG, Ueda M, Zhu X, Perry G, Smith MA (2006) Ectopic expression of phospho-Smad2 in Alzheimer’s disease: uncoupling of the transforming growth factor-beta pathway? J Neurosci Res 84:1856–1861

    Article  CAS  PubMed  Google Scholar 

  34. Tesseur I, Zou K, Esposito L, Bard F, Berber E, Can JV et al (2006) Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer’s pathology. J Clin Invest 116:3060–3069

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Ueberham U, Ueberham E, Gruschka H, Arendt T (2006) Altered subcellular location of phosphorylated Smads in Alzheimer’s disease. Eur J Neurosci 24:2327–2334

    Article  PubMed  Google Scholar 

  36. Chalmers KA, Love S (2007) Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. J Neuropathol Exp Neurol 66:158–167

    CAS  PubMed  Google Scholar 

  37. Mocali A, Cedrola S, Della Malva N, Bontempelli M, Mitidieri VA, Bavazzano A et al (2004) Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease. Exp Gerontol 39:1555–1561

    Article  CAS  PubMed  Google Scholar 

  38. Juraskova B, Andrys C, Holmerova I, Solichova D, Hrnciarikova D, Vankova H et al (2010) Transforming growth factor beta and soluble endoglin in the healthy senior and in Alzheimer’s disease patients. J Nutr Health Aging 14:758–761

    Article  CAS  PubMed  Google Scholar 

  39. Luppi C, Fioravanti M, Bertolini B, Grugnetti A, Inguscio M, Guerriero F et al (2009) Growth factors decrease in subjects with mild to moderate Alzheimer’s disease (AD): potential correction with dehydroepiandrosteronesulphate (DHEAS). Arch Gerontol Geriatr 49:173–184

    Article  CAS  PubMed  Google Scholar 

  40. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J et al (2009) Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462:315–322

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  41. Selkoe DJ (2001) Alzheimer’s disease: genes, proteins, and therapy. Physiol Rev 81:741–766

    CAS  PubMed  Google Scholar 

  42. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM et al (2000) Inflammation and Alzheimer’s disease. Neurobiol Aging 21(3):383–421

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This work was supported in part by the grants (30171008, 30700980) from the Beijing Natural Science Foundation of China.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Neurology, Shengjing Hospital of China Medical University, Shenyang, 110817, People’s Republic of China

    Lin Cong

  2. Department of Neurology, First Affiliated Hospital, China Medical University, Heping District, Shenyang, People’s Republic of China

    Yan Ren

  3. Department of Neurology, Xuanwu Hospital, Capital Medical University, Beijing, People’s Republic of China

    Jianping Jia, Wei Qin & Yongxin Sun

Authors
  1. Lin Cong
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jianping Jia
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Wei Qin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yongxin Sun
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Yan Ren or Yongxin Sun.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cong, L., Jia, J., Qin, W. et al. Genome-wide analysis of DNA methylation in an APP/PS1 mouse model of Alzheimer’s disease. Acta Neurol Belg 114, 195–206 (2014). https://doi.org/10.1007/s13760-013-0267-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13760-013-0267-6

Keywords

Search

Navigation